Artiva Operating Cycle from 2010 to 2026
| ARTV Stock | 3.87 0.15 3.73% |
Operating Cycle | First Reported 2010-12-31 | Previous Quarter 191.08 | Current Value 200.63 | Quarterly Volatility 52.36986443 |
Check Artiva Biotherapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Artiva Biotherapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 6.5 M, Interest Income of 6.5 M or Depreciation And Amortization of 2.9 M, as well as many indicators such as Price To Sales Ratio of 925, Dividend Yield of 0.0 or PTB Ratio of 1.24. Artiva financial statements analysis is a perfect complement when working with Artiva Biotherapeutics Valuation or Volatility modules.
Artiva | Operating Cycle | Build AI portfolio with Artiva Stock |
The evolution of Operating Cycle for Artiva Biotherapeutics Common provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Artiva Biotherapeutics compares to historical norms and industry peers.
Latest Artiva Biotherapeutics' Operating Cycle Growth Pattern
Below is the plot of the Operating Cycle of Artiva Biotherapeutics Common over the last few years. It is Artiva Biotherapeutics' Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Artiva Biotherapeutics' overall financial position and show how it may be relating to other accounts over time.
| Operating Cycle | 10 Years Trend |
|
Operating Cycle |
| Timeline |
Artiva Operating Cycle Regression Statistics
| Arithmetic Mean | 99.17 | |
| Geometric Mean | 86.81 | |
| Coefficient Of Variation | 52.81 | |
| Mean Deviation | 36.06 | |
| Median | 85.32 | |
| Standard Deviation | 52.37 | |
| Sample Variance | 2,743 | |
| Range | 193 | |
| R-Value | 0.45 | |
| Mean Square Error | 2,331 | |
| R-Squared | 0.20 | |
| Significance | 0.07 | |
| Slope | 4.68 | |
| Total Sum of Squares | 43,882 |
Artiva Operating Cycle History
About Artiva Biotherapeutics Financial Statements
Artiva Biotherapeutics investors use historical fundamental indicators, such as Artiva Biotherapeutics' Operating Cycle, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Artiva Biotherapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Operating Cycle | 191.08 | 200.63 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Artiva Stock Analysis
When running Artiva Biotherapeutics' price analysis, check to measure Artiva Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Artiva Biotherapeutics is operating at the current time. Most of Artiva Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Artiva Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Artiva Biotherapeutics' price. Additionally, you may evaluate how the addition of Artiva Biotherapeutics to your portfolios can decrease your overall portfolio volatility.